CC BY-NC-ND 4.0 · J Lab Physicians 2016; 8(02): 085-089
DOI: 10.4103/0974-2727.180787
Original Article

Chikungunya Fever Among Patients with Acute Febrile Illness Attending a Tertiary Care Hospital in Mumbai

Lata Baswanna Galate
Department of Microbiology, GMC, Akola, Maharashtra, India
,
Sachee R Agrawal
Department of Microbiology, Nair Charitable Hospital, Mumbai, Maharashtra, India
,
Jayanthi S Shastri
Department of Microbiology, Nair Charitable Hospital, Mumbai, Maharashtra, India
,
Vikram Londhey
Department of Medicine, TNMC and BYL, Nair Charitable Hospital, Mumbai, Maharashtra, India
› Author Affiliations
Financial support and sponsorship: Nil.

ABSTRACT

Background: Chikungunya fever (CHIK) is an arboviral disease. Dengue fever (DENG) and CHIK are indistinguishable clinically and need to be differentiated by laboratory investigations.

Purpose: This study aimed at estimating the seroprevalence of CHIK mono-infection and CHIK and DENG dual infection in suspected patients. We also analyzed the age, sex distribution, joint involvement, and relation of joint movement restriction with visual analog scale (VAS).

Materials and Methods: Two hundred patients clinically suspected with DENG and CHIK were enrolled from a Tertiary Care Hospital in Mumbai from April 2012 to October 2013. The detailed history and examination findings were recorded. Serum samples were subjected to DENG and CHIK immunoglobulin G (IgM) enzyme-linked immunosorbent assay (ELISA).

Results: The seroprevalence of CHIK was 12.5%. Mono-infection of CHIK was 3%, and CHIK and DENG dual infection was 9.5%. Most affected age group in CHIK cases was 46–60 years wherein female preponderance was seen. All 6 patients with CHIK mono-infection had fever and joint involvement; knee and elbow were the most commonly affected joints. All CHIK patients had VAS score of 6–10 with restricted joint movement. Of the patients with dual infection, the majorities were from 31 to 45 years with male preponderance; all had fever and joint pain mainly affecting knee and elbow. Of patients who had VAS score 6–10 in patients with dual infection, only 5.26% had restricted joint movement.

Conclusion: IgM ELISA for Chikungunya infection should be included in the routine laboratory tests for acute febrile illness.



Publication History

Article published online:
19 April 2020

© 2016.

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 
  • REFERENCES

  • 1 Brooks GF, Butel JS, Morse SA. Human arboviral infections. In: Jawetz, Melnick and Adelberg′s Medical Microbiology. 23rd ed. Singapore: McGraw Hill; 2004. p. 514-24.
  • 2 Schuffenecker I, Iteman I, Michault A, Murri S, Frangeul L, Vaney MC, et al. Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak. PLoS Med 2006;3:e263.
  • 3 Vanlandingham DL, Hong C, Klingler K, Tsetsarkin K, McElroy KL, Powers AM, et al. Differential infectivities of o′nyong-nyong and chikungunya virus isolates in Anopheles gambiae and Aedes aegypti mosquitoes. Am J Trop Med Hyg 2005;72:616-21.
  • 4 Strauss JH, Strauss EG. The alphaviruses: Gene expression, replication, and evolution. Microbiol Rev 1994;58:491-562.
  • 5 Fields BN, Knipe DM, Howley PM, editors. Alphaviruses. In: Fields Virology. 3 rd ed., Vol. 1. Philadelphia: Lippincott-Raven Publishers; 1996. p. 858-98.
  • 6 Chikungunya in India: Global Alert and Response; 2006. [Cited for Epidemiology of Chikungunya]. Available from: http://www.who.int/csr/don/2006_10_17/en/.
  • 7 Jadhav M, Namboodripad M, Carman RH, Carey DE, Myers RM. Chikungunya disease in infants and children in Vellore: A report of clinical and haematological features of virologically proved cases. Indian J Med Res 1965;53:764-76.
  • 8 Myers RM, Carey DE. Concurrent isolation from patient of two arboviruses, chikungunya and dengue type 2. Science 1967;157:1307-8.
  • 9 Barrett AD, Weaver SC. Arboviruses: Alphaviruses, flaviviruses and bunyaviruses. In: Greenwood D, Slack RC, Peutherer JF, editors. Medical Microbiology. 16 th ed. London: Churchill Livingstone; 2002. p. 484-501.
  • 10 Diallo M, Thonnon J, Traore-Lamizana M, Fontenille D. Vectors of chikungunya virus in Senegal: Current data and transmission cycles. Am J Trop Med Hyg 1999;60:281-6.
  • 11 Definition of Chikungunya Fever. Available from: http://www.searo.who.int/entity/emerging_diseases/topics/Def_Chikungunya_Fever.pdf.
  • 12 Visual Analogue Scale. Available from: https://en.wikipedia.org/wiki/Visual_analogue_scale.
  • 13 Clinical Profile of Chikungunya Fever. Available from: http://www.apiindia.org/pdf/pg_med_2008/Chapter-42.pdf.
  • 14 Kalawat U, Sharma KK, Reddy SG. Prevalence of dengue and chickungunya fever and their co-infection. Indian J Pathol Microbiol 2011;54:844-6.
  • 15 Mohanty I, Dash M, Sahu S, Narasimham MV, Panda P, Padhi S. Seroprevalence of chikungunya in Southern Odisha. J Family Med Prim Care 2013;2:33-6.
  • 16 Suryawanshi SD, Dube AH, Khadse RK, Jalgaonkar SV, Sathe PS, Zawar SD, et al. Clinical profile of chikungunya fever in patients in a tertiary care centre in Maharashtra, India. Indian J Med Res 2009;129:438-41.
  • 17 Chandra P, Das B, Sowmya MK, Samanta S, Thimmaraju KV. Epidemiologal study on chikungunya outbreak in Mangalore district, Karnataka. Int J Pharma Bio Sci 2011;2:343-7.
  • 18 Mohan A, Kiran DH, Manohar IC, Kumar DP. Epidemiology, clinical manifestations, and diagnosis of chikungunya fever: Lessons learned from the re-emerging epidemic. Indian J Dermatol 2010;55:54-63.
  • 19 Ray P, Ratagiri VH, Kabra SK, Lodha R, Sharma S, Sharma BS, et al. Chikungunya infection in India: Results of a prospective hospital based multi-centric study. PLoS One 2012;7:e30025.
  • 20 Murhekar MV, Manickam P, Kumar RM, Ganesakumar SR, Ramachandran V, Ramakrishnan R, et al. Treatment practices and laboratory investigations during chikungunya outbreaks in South India. Indian J Med Res 2011;133:546-7.